BREAKTHROUGH OF THE YEAR:
Bioterrorism: The Calm After the Storm
Martin Enserink
The 11 September terrorist attacks and the mysterious anthrax letters are beginning to put their stamp on the research enterprise. But although 2002 has been marked by much talk about bioterror, it has also become a year of waiting for action, with major decisions on research funding, regulation, and smallpox vaccination stalled by politics and technical debate.